BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 19538232)

  • 1. Mechanisms of glucose intolerance in cystic fibrosis.
    Mohan K; Miller H; Dyce P; Grainger R; Hughes R; Vora J; Ledson M; Walshaw M
    Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status.
    Lavie M; Fisher D; Vilozni D; Forschmidt R; Sarouk I; Kanety H; Hemi R; Efrati O; Modan-Moses D
    Diabetes Res Clin Pract; 2015 Dec; 110(3):276-84. PubMed ID: 26508676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis.
    Tofé S; Moreno JC; Máiz L; Alonso M; Escobar H; Barrio R
    Eur J Endocrinol; 2005 Feb; 152(2):241-7. PubMed ID: 15745932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program.
    Sterescu AE; Rhodes B; Jackson R; Dupuis A; Hanna A; Wilson DC; Tullis E; Pencharz PB
    J Pediatr; 2010 Apr; 156(4):613-7. PubMed ID: 19962154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose ≥155 mg/dL.
    Nyirjesy SC; Sheikh S; Hadjiliadis D; De Leon DD; Peleckis AJ; Eiel JN; Kubrak C; Stefanovski D; Rubenstein RC; Rickels MR; Kelly A
    Pediatr Diabetes; 2018 Nov; 19(7):1173-1182. PubMed ID: 29885044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose Tolerance Stages in Cystic Fibrosis Are Identified by a Unique Pattern of Defects of Beta-Cell Function.
    Piona C; Volpi S; Zusi C; Mozzillo E; Tosco A; Franzese A; Raia V; Boselli ML; Trombetta M; Cipolli M; Bonadonna RC; Maffeis C
    J Clin Endocrinol Metab; 2021 Mar; 106(4):e1793-e1802. PubMed ID: 33331877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.
    Yung B; Noormohamed FH; Kemp M; Hooper J; Lant AF; Hodson ME
    Diabet Med; 2002 Mar; 19(3):221-6. PubMed ID: 11963922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.
    Ripa P; Robertson I; Cowley D; Harris M; Masters IB; Cotterill AM
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):383-9. PubMed ID: 11940051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose tolerance.
    Merjaneh L; He Q; Long Q; Phillips LS; Stecenko AA
    J Cyst Fibros; 2015 Jan; 14(1):135-41. PubMed ID: 24998161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of insulin secretion indices in cystic fibrosis patients.
    Hammana I; Potvin S; Tardif A; Berthiaume Y; Coderre L; Rabasa-Lhoret R
    J Cyst Fibros; 2009 Dec; 8(6):378-81. PubMed ID: 19782008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
    Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis.
    Cano Megías M; González Albarrán O; Guisado Vasco P; Lamas Ferreiro A; Máiz Carro L
    Endocrinol Nutr; 2015 Feb; 62(2):91-9. PubMed ID: 25444978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical importance of cystic fibrosis-related diabetes.
    Brennan AL; Geddes DM; Gyi KM; Baker EH
    J Cyst Fibros; 2004 Dec; 3(4):209-22. PubMed ID: 15698938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.
    Clemente León M; Bilbao Gassó L; Moreno-Galdó A; Campos Martorrell A; Gartner Tizzano S; Yeste Fernández D; Carrascosa Lezcano A
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):45-51. PubMed ID: 29137964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
    Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between exercise capacity and glucose tolerance in cystic fibrosis.
    Foster K; Huang G; Zhang N; Crisalli J; Chini B; Amin R; Elder D
    Pediatr Pulmonol; 2018 Feb; 53(2):154-161. PubMed ID: 29115018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
    Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
    Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
    Bonhoure A; Potter KJ; Colomba J; Boudreau V; Bergeron C; Desjardins K; Carricart M; Tremblay F; Lavoie A; Rabasa-Lhoret R
    Diabetologia; 2021 Jun; 64(6):1332-1341. PubMed ID: 33693987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study.
    Bellin MD; Laguna T; Leschyshyn J; Regelmann W; Dunitz J; Billings J; Moran A
    Pediatr Diabetes; 2013 Sep; 14(6):417-21. PubMed ID: 23952705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.
    Limoli DH; Yang J; Khansaheb MK; Helfman B; Peng L; Stecenko AA; Goldberg JB
    Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):947-53. PubMed ID: 26993289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.